Premium
The usefulness of power Doppler ultrasonography for diagnosing prostate cancer: histological correlation of each biopsy site
Author(s) -
Franco O.E.,
Arima K.,
Yanagawa M.,
Kawamura J.
Publication year - 2000
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1046/j.1464-410x.2000.00669.x
Subject(s) - medicine , vascularity , biopsy , prostate , prostate cancer , radiology , transrectal ultrasonography , rectal examination , carcinoma , prostate biopsy , ultrasonography , urology , cancer , pathology
Objective To correlate the findings of power Doppler ultrasonography (PDUS) of the prostate with those of site‐specific transrectal ultrasonography (TRUS)‐guided biopsy. Patients and methods The study comprised 28 patients referred to our institution for TRUS‐guided prostate biopsy because of an elevated PSA level and/or abnormal digital rectal examination. PDUS findings were graded 0, 1 or 2; grades 0–1 were considered as negative and grade 2 as positive. The blood volume of each biopsy site was also determined using the mean number (MN) value that represents the average vascularity in a 5‐mm square sample. PDUS values were correlated with the histological findings of 147 biopsies with 19 focal lesions. Results Grade 2 was assigned to 19 sites, grade 1 to 52 sites, and grade 0 to 76 sites. Fourteen of the 19 PDUS findings of grade 2 sites revealed carcinoma and five were grade 1. Ten of 35 TRUS‐positive sites were carcinomas, three benign prostatic hyperplasia (BPH) and 22 normal. The MN value for prostatic carcinoma was 4.33, for BPH 11.7 and for normal tissue 4.7. The overall sensitivity of PDUS was 74%, the specificity 96% and the positive predictive value 74%. Conclusions Because TRUS alone cannot detect all cancers, PDUS should be used routinely in all patients undergoing TRUS‐guided biopsy, to improve the diagnostic yield of prostate cancer.